Navigation Links
Lung Cancer Alliance Commends Leadership of MA State Senate
Date:3/13/2008

First-ever State Funded Lung Cancer Research Bill Given Hearing in Joint Committee on Revenue

WASHINGTON, March 13 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance praised the efforts of State Senator Susan Fargo for helping shepherd first-ever lung cancer research funding bill through the Massachusetts State Senate Committee on Revenue. Senate Bill #2454 would establish a "trust fund," known as the Commonwealth Lung Cancer Early Detection and Treatment Research Fund, which would be funded by a percentage of the cigarette tax and would support research grants for early detection and treatment.

"Lung cancer is the leading cause of cancer death among men and women nationally and in Massachusetts," said Senator Fargo. "This year alone 3,360 Massachusetts residents will succumb to this disease. This is unacceptable, and it is time that we addressed this public health epidemic with the compassion and support it rightly deserves. I am confident that Massachusetts can and will lead the way."

Dozens filled the committee room to testify or submitted letters in support of the legislation. "No one deserves lung cancer," said Diane Legg, a survivor and State Co-Chairwoman of Lung Cancer Alliance - Massachusetts (LCA-MA). "This is one of the most exciting days for me since my lung cancer diagnosis. Fortunately my lung cancer was caught early -- which is why helping others at risk detect and treat their lung cancer earlier is absolutely critical. Thank you, Senator Fargo for your leadership on this issue."

Lung cancer claims more lives each year than breast, prostate, colon, liver, kidney and melanoma cancers combined. Over 70% of those diagnosed with lung cancer are diagnosed at late stage which accounts for its low five-year survival rate of 15%. In addition, 60% of those now diagnosed quit smoking decades ago or never smoked at all.

"It makes no difference whether you smoked or not," said Joanne O'Connor, who lost her sister to lung cancer and is LCA-MA State Co-Chairwoman. "What matters is that lung cancer is a disease and no longer should be ignored or stigmatized. Too many are dying needlessly because of the lack of more robust early detection and treatment programs."

The Joint Committee on Revenue will have until March 19th to act on the bill. The bill will proceed to the Ways and Means Committee if ruled upon favorably. LCA-MA will continue to collaborate with all other public health leaders, including the American Lung Association of New England, to advance this ground breaking legislation.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer. Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Panel Supports Anemia Drugs for Cancer Patients
2. Womens Risk for a Certain Skin Cancer Varies by Geography
3. Is increased Slug expression associated with the progression to esophageal cancer?
4. Routinely used diagnostic approaches: only limited diagnostic sensitivity for bile duct cancer?
5. American Cancer Society science reporters briefing to feature latest developments in cancer
6. FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients
7. Cancer Survivors Lobby Lifetime TV to Order More of Side Order of Life
8. DNA detectives find genetic markers for lung cancers most likely to recur
9. Researchers find cause of severe allergic reaction to cancer drug
10. Doctors See How Cancer Drug Can Damage Kidneys
11. Genetic Markers May Predict Lung Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy ... enhancement of their 503A compounding pharmacy located in Ocala, Florida. , Meeting ... and patients throughout the United States for high-quality human anti-aging and wellness ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... Somerset, N.J. (PRWEB) , ... January 19, 2017 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Medicines with Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery ...
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, ... fillers that resulted in severe facial disfiguration. After four frightening years of isolation ... at UCLA Medical Center, who removed the substances in a partial facial transplant ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical Academy (UMA) ... are passionate about making a difference in the lives of the next generation ... a nonprofit healthcare educational institution, has more than 30,000 alumni and employs more ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 Pfizer ... the Milner Therapeutics Consortium   Major ... Cambridge   The Milner ... PFE ) as a partner to the Milner Therapeutics ... enables the efficient transfer of materials between industry and ...
(Date:1/19/2017)... 18, 2017  ViewRay, Inc. (Nasdaq: ... only clinical MRI-guided radiation therapy system, announced today that ... $26.1 million through a private placement of its ... the financing and was joined by certain of ... Kearny Venture Partners, and an additional new institutional ...
(Date:1/19/2017)... Jan. 18, 2017 The Academy of ... Drug Administration (FDA) for its release today of ... health decision makers can proactively share clinical and ... well as emerging therapies awaiting FDA approval. ... recommendations that AMCP developed during two multi-stakeholder meetings ...
Breaking Medicine Technology: